Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non-Small-Cell Lung Cancer
Paz-Ares, L. G., Biesma, B., Heigener, D., von Pawel, J., Eisen, T., Bennouna, J., Zhang, L., Liao, M., Sun, Y., Gans, S., Syrigos, K., Le Marie, E., Gottfried, M., Vansteenkiste, J., Alberola, V., StVolume:
30
Language:
english
Pages:
9
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2011.39.7646
Date:
September, 2012
File:
PDF, 163 KB
english, 2012